A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s78911
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search